SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015029
Filing Date
2021-11-08
Accepted
2021-11-08 16:07:22
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20210930x10q.htm   iXBRL 10-Q 2168877
2 EX-31.1 ocul-20210930xex31d1.htm EX-31.1 12012
3 EX-31.2 ocul-20210930xex31d2.htm EX-31.2 8452
4 EX-32.1 ocul-20210930xex32d1.htm EX-32.1 4999
5 EX-32.2 ocul-20210930xex32d2.htm EX-32.2 4980
  Complete submission text file 0001558370-21-015029.txt   6582630

Data Files

Seq Description Document Type Size
6 EX-101.SCH ocul-20210930.xsd EX-101.SCH 42660
7 EX-101.CAL ocul-20210930_cal.xml EX-101.CAL 50021
8 EX-101.DEF ocul-20210930_def.xml EX-101.DEF 119880
9 EX-101.LAB ocul-20210930_lab.xml EX-101.LAB 322961
10 EX-101.PRE ocul-20210930_pre.xml EX-101.PRE 270108
11 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20210930x10q_htm.xml XML 1022284
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 211387957
SIC: 2834 Pharmaceutical Preparations